Paris, December 17, 2025 – Jeantet advised Synlab group on the sale of its majority stake in the share capital of BARLA (Biologistes Associés Regroupant des Laboratoires d’Analyses), operating a multi-site medical biology laboratory in the Alpes-Maritimes and Var regions, to Inovie Labosud. The entire transaction was carried out in full agreement and collaboration with BARLA’s biologists.
Synlab group is a leader in medical diagnostics in biology, anatomo-cytopathology, and medical genetics in Europe, has a European network of more than 300 sites in over 30 countries across four continents, employing nearly 18,000 employees and medical staff and performing 450 million tests each year.
The Jeantet team comprised Karl Hepp de Sevelinges and Ruben Koslar (Partners, Corporate/M&A), Georges-Dominic Sardi and Emma Rouhaud (Associates, Corporate/M&A), as well as Gabriel di Chiara (Partner, Tax) on the tax aspects of the transaction.
The Synlab team comprised Jalila Gouich (General Counsel Synlab France), Nicolas Camaret (Synlab Group Head of M&A) and Rida Boulmezzaoud (Synlab France Deputy legal director).
Download the press release





